Jonathan S. Lewin, MD, was recently named the 115th president of American Roentgen Ray Society at its annual meeting last month in Toronto. He succeeds Melissa Rosado de Christenson, who served as ARRS president from 2014 to 2015.
Touching on the current state of health care in the United States, his acceptance speech advised radiologists to be prepared for the impact of escalating health care costs and the transition from volume- to a value-based care. Specifically, he encouraged radiologists to use the challenge “as the sun rising on a new and even more exciting era in which we can have an even greater positive effect impact on our patients.”
Lewin serves as the senior vice president for integrated health care delivery and as co-chair for strategic planning at Johns Hopkins Medicine. He is also the Martin Donner professor and chairman of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University and radiologist-in-chief at The Johns Hopkins Hospital, with secondary appointments as professor of oncology, neurosurgery and biomedical engineering.
A pioneer in interventional and intraoperative MRI, Lewin’s work has contributed to more than 20 patents. He has also published approximately 190 peer-reviewed manuscripts and more than 60 chapters, reviews, commentaries and other invited papers on topics including the basic science and clinical aspects of interventional and functional MRI and other areas of neuroradiology.
Lewin holds his undergraduate degree in chemistry from Brown University and completed medical school at Yale University in 1985. He interned at Yale-New Haven Hospital and served his residency in diagnostic radiology at University Hospitals of Cleveland, after which he completed an MRI research fellowship in Germany, a neuroradiology fellowship at the Cleveland Clinic and additional training in head and neck radiology at the Pittsburgh Eye and Ear Hospital.
Additionally, Lewin has served on numerous national committees, editorial boards and grant review groups for foundations and the National Institutes of Health and on the Task Force on Minimally-Invasive Cancer Therapy for the National Cancer Institute.
Get AXIS e-newsletters free. Subscribe here.
